arrow
P

Paolo Ambrosino

university of sannio
H指数:28
被引数:2,469

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

In Silico Assisted Identification, Synthesis, and In Vitro Pharmacological Characterization of Potent and Selective Blockers of the Epilepsy-Associated KCNT1 Channel
2024-05-235
OAAI
A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: Precision medicine approach with fluoxetine

一种引起发育性和癫痫性脑病的新型KCNC1功能获得变体: 氟西汀的精准医学方法

2023-06-0211
PRE
KCNT2-Related Disorders: Phenotypes, Functional, and Pharmacological Properties

KCNT2-Related障碍: 表型、功能和药理学特性

2023-05-2212
OA
KCNQ2 R144 variants cause neurodevelopmental disability with language impairment and autistic features without neonatal seizures through a gain-of-function mechanism
2022-07-0121
OAAI
Gain of function due to increased opening probability by two KCNQ5 pore variants causing developmental and epileptic encephalopathy
2022-04-0418
OA
Calcium cytotoxicity sensitizes prostate cancer cells to standard-of-care treatments for locally advanced tumors

钙细胞毒性使前列腺癌细胞对局部晚期肿瘤的标准治疗敏感

2020-12-0720
OAAI
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy

加巴喷丁治疗KCNQ2发展性癫痫脑病患者

2020-10-0110
OAAI
Synthesis and Pharmacological Characterization of Conformationally Restricted Retigabine Analogues as Novel Neuronal Kv7 Channel Activators

构象限制的瑞替加滨类似物作为新型神经元Kv7通道激活剂的合成和药理学表征

2019-12-0927
OAAI
Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy

奎尼丁早期治疗2例因功能获得性KCNT1突变引起的迁移性局灶性癫痫发作 (EIMFS) 的婴儿期癫痫患者: 功能研究,临床反应和个性化治疗的关键问题

2018-10-0151
OAAI
Infantile spasms and encephalopathy without preceding neonatal seizures caused by KCNQ2 R198Q, a gain-of-function variant

由KCNQ2 R198Q引起的婴儿痉挛和脑病,没有先前的新生儿癫痫发作,这是一种功能获得变体

2016-11-0984
OAAI